PLIANT THERAPEUTICS INC's ticker is PLRX and the CUSIP is 729139105. A total of 136 filers reported holding PLIANT THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is 1.31 and the average weighting 1.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $82,657 | +681.3% | 7,689 | +983.0% | 0.00% | – |
Q1 2024 | $10,579 | -96.0% | 710 | -95.1% | 0.00% | -100.0% |
Q4 2023 | $261,562 | +64.5% | 14,443 | +57.5% | 0.00% | -40.0% |
Q3 2023 | $159,008 | +258.3% | 9,170 | +274.4% | 0.01% | +400.0% |
Q2 2023 | $44,376 | +260935.3% | 2,449 | +271.6% | 0.00% | 0.0% |
Q1 2023 | $17 | -46.9% | 659 | -59.7% | 0.00% | 0.0% |
Q4 2022 | $32 | -100.0% | 1,635 | -69.8% | 0.00% | -50.0% |
Q3 2022 | $113,000 | +352.0% | 5,412 | +73.3% | 0.00% | +100.0% |
Q2 2022 | $25,000 | +56.2% | 3,123 | +37.6% | 0.00% | – |
Q1 2022 | $16,000 | -27.3% | 2,270 | +39.3% | 0.00% | – |
Q4 2021 | $22,000 | +100.0% | 1,630 | +130.6% | 0.00% | – |
Q3 2021 | $11,000 | -76.1% | 707 | -55.6% | 0.00% | -100.0% |
Q2 2021 | $46,000 | -24.6% | 1,591 | +2.2% | 0.00% | 0.0% |
Q1 2021 | $61,000 | +110.3% | 1,557 | +24.4% | 0.00% | 0.0% |
Q4 2020 | $29,000 | -71.0% | 1,252 | -71.7% | 0.00% | 0.0% |
Q3 2020 | $100,000 | – | 4,425 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Mass General Brigham, Inc | 288,690 | $3,103,418 | 15.11% |
TRV GP IV, LLC | 2,132,867 | $22,928,320 | 11.34% |
Blue Owl Capital Holdings LP | 3,004,199 | $32,295,139 | 8.98% |
GREAT POINT PARTNERS LLC | 2,636,864 | $28,346,288 | 5.43% |
First Light Asset Management, LLC | 3,401,213 | $36,563,040 | 3.20% |
Redmile Group, LLC | 3,209,591 | $34,503,103 | 2.09% |
Deep Track Capital, LP | 5,972,257 | $64,201,763 | 1.92% |
Fernwood Investment Management, LLC | 496,286 | $5,335,075 | 1.66% |
Checkpoint Capital L.P. | 232,200 | $2,496,150 | 1.50% |
Exome Asset Management LLC | 124,000 | $1,333,000 | 1.16% |